Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100

Zimmer Biomet Holdings, Inc. (ZBH) Total debt

Alert me on Total debt

Zimmer Biomet Holdings, Inc.'s total debt at the end of fiscal 2025 was $7.5B, up 21.2% from $6.2B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $7.5B. Over the past ten years it has ranged from $5.7B (fiscal 2022) to $11.5B (fiscal 2015); the current reading is higher than 45% of that period. Zimmer Biomet Holdings, Inc. ranks 6th of 147 Medical Devices companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $7.5B 21.19%
FY2024 $6.2B 7.57%
FY2023 $5.8B 1.25%
FY2022 $5.7B (19.41%)
FY2021 $7.1B (13.02%)
FY2020 $8.1B (1.15%)
FY2019 $8.2B (8.02%)
FY2018 $8.9B (11.87%)
FY2017 $10.1B (9.78%)
FY2016 $11.2B (2.23%)

Quarterly newest first

Period Total debt Change
Jun 2026 $7.5B 0.11%
Mar 2026 $7.5B (0.64%)
Dec 2025 $7.5B (7.32%)
Sep 2025 $8.1B 7.13%
42 more quarters

Against its own ten years

Low $5.7B High $11.5B
Ten-year median $8.1B
Current reading's percentile 45

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on ZBH